Guggulsterone (GS) inhibits smokeless tobacco and nicotine-induced NF-κB and STAT3 pathways in head and neck cancer cells

Carcinogenesis

Volumn 32, Issue 3, 2011, Pages 368-380

  Macha, Muzafar A ^a   Matta, Ajay ^b   Chauhan, S S ^a   Michael Siu, K W ^b   Ralhan, Ranju ^b,c,d  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b YORK UNIVERSITY   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; GUGGULSTERONE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; NICOTINE; PROTEIN SUBUNIT; STAT3 PROTEIN; SYNAPTOTAGMIN I; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CELL; COMPETITIVE INHIBITION; CONTROLLED STUDY; CYTOKINE RELEASE; ENHANCER REGION; HEAD AND NECK CANCER; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SMOKELESS TOBACCO; WESTERN BLOTTING;

EID: 79952294625     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq278     Document Type: Article

References (50)

1. Shafey,O. et al. (2009) The Tobacco Atlas. American Cancer Society, Atlanta, GA.
2. World Health Organization (2009) Tobacco Key Facts. http://www.who.int/topics/tobacco/facts/en/index.html (Accessed March 29, 2010).
3. Centers for Disease Control and Prevention (2009) Smoking & Tobacco Use. [Cited January 15, 2010]; Trends in Current Cigarette Smoking Among High School Students and Adults, United States, 1965-2007]. http://www.cdc.gov/tobacco/data_statistics/tables/trends/cig_smoking/index.htm. Accessed March 29, 2010.
4. Centers for Disease Control and Prevention (2009) Cigarette smoking among adults and trends in smoking cessation-United States, 2008. MMWR Morb. Mortal. Wkly. Rep., 58, 1227-1232.
5. Viswanath,K. et al. (2010) Tobacco and cancer: an American Association for Cancer Research policy statement. Cancer Res., 70, 3419-3430.
6. Secretan,B. et al. (2009) A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol., 10, 1033-1034.
7. International Agency for Research on Cancer Working Group on the Evaluation of Carcinogenic Risks to Humans (2007) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 89: Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines. IARC, Lyon.
8. Jemal,A. et al. (2009) Cancer statistics. CA Cancer J. Clin., 59, 225-249.
9. Argiris,A. et al. (2008) Head and neck cancer. Lancet, 371, 1695-1709.
10. Righini,C.A. et al. (2008) [Risk factors for cancers of the oral cavity, pharynx (cavity excluded) and larynx]. Presse. Med., 37, 1229-1240.
11. Lee,P.N. et al. (2009) The relation between smokeless tobacco and cancer in Northern Europe and North America. A commentary on differences between the conclusions reached by two recent reviews. BMC Cancer, 9, 256.
12. Petersen,P.E. (2009) Oral cancer prevention and control-the approach of the World Health Organization. Oral Oncol., 45, 454-460.
13. Cogliano,V. et al. (2004) Smokeless tobacco and tobacco-related nitrosamines. Lancet Oncol., 5, 708.
14. Stepanov,I. et al. (2010) Analysis of 23 polycyclic aromatic hydrocarbons in smokeless tobacco by gas chromatography-mass spectrometry. Chem. Res. Toxicol., 23, 66-73.
15. Xu,J. et al. (2007) Nicotine inhibits apoptosis induced by cisplatin in human oral cancer cells. Int. J. Oral Maxillofac. Surg., 36, 739-744.
16. Jayasurya,R. et al. (2005) Phenotypic alterations in Rb pathway have more prognostic influence than p53 pathway proteins in oral carcinoma. Mod. Pathol., 18, 1056-1066.
17. Mishra,R. et al. (2005) Activation of STAT 5-cyclin D1 pathway in chewing tobacco mediated oral squamous cell carcinoma. Mol. Biol. Rep., 32, 159-166.
18. Warnakulasuriya,K.A. et al. (2007) Clinical, pathological, cellular and molecular lesions caused by oral smokeless tobacco-a review. J. Oral Pathol. Med., 36, 63-77.
19. Kaur,J. et al. (2010) Clinical significance of phosphatidyl inositol synthase overexpression in oral cancer. BMC Cancer, 10, 168.
20. Coppe,J.P. et al. (2008) A role for fibroblasts in mediating the effects of tobacco-induced epithelial cell growth and invasion. Mol. Cancer Res., 6, 1085-1098.
21. Ondrey,F.G. et al. (1999) Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines. Mol. Carcinog., 26, 119-129.
22. Sawhney,M. et al. (2007) Expression of NF-kappaB parallels COX-2 expression in oral precancer and cancer: association with smokeless tobacco. Int. J. Cancer, 120, 2545-2556.
23. Aggarwal,B.B. (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell, 6, 203-208.
24. Rohatgi,N. et al. (2005) Smokeless tobacco (khaini) extracts modulate gene expression in epithelial cell culture from an oral hyperplasia. Oral Oncol., 41, 806-820.
25. Squarize,C.H. et al. (2006) Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma. Neoplasia, 8, 733-746.
26. Macha,M.A. et al. (2010) Prognostic significance of nuclear pSTAT3 in oral cancer. Head Neck, Jul 22. [Epub ahead of print].
27. Shishodia,S. et al. (2008) The guggul for chronic diseases: ancient medicine, modern targets. Anticancer Res., 28, 3647-3664.
28. Shishodia,S. et al. (2004) Guggulsterone inhibits NF-kappaB and IkappaBalpha kinase activation, suppresses expression of antiapoptotic gene products, and enhances apoptosis. J. Biol. Chem., 279, 47148-47158.
29. Singh,S.V. et al. (2005) Caspase-dependent apoptosis induction by guggulsterone, a constituent of Ayurvedic medicinal plant Commiphora mukul, in PC-3 human prostate cancer cells is mediated by Bax and Bak. Mol. Cancer Ther., 4, 1747-1754.
30. Samudio,I. et al. (2005) Guggulsterones induce apoptosis and differentiation in acute myeloid leukemia: identification of isomer-specific antileukemic activities of the pregnadienedione structure. Mol. Cancer Ther., 4, 1982-1992.
31. Shishodia,S. et al. (2007) Guggulsterone inhibits tumor cell proliferation, induces S-phase arrest, and promotes apoptosis through activation of c-Jun N-terminal kinase, suppression of Akt pathway, and downregulation of antiapoptotic gene products. Biochem. Pharmacol., 74, 118-130.
32. Singh,S.V. et al. (2007) Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase. Cancer Res., 67, 7439-7449.
33. An,M.J. et al. (2009) Guggulsterone induces apoptosis in colon cancer cells and inhibits tumor growth in murine colorectal cancer xenografts. Cancer Lett., 279, 93-100.
34. Ahn,K.S. et al. (2008) Guggulsterone, a farnesoid X receptor antagonist, inhibits constitutive and inducible STAT3 activation through induction of a protein tyrosine phosphatase SHP-1. Cancer Res., 68, 4406-4415.
35. Leeman-Neill,R.J. et al. (2009) Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3. Carcinogenesis, 30, 1848-1856.
36. Kim,E.S. et al. (2008) Guggulsterone inhibits angiogenesis by blocking STAT3 and VEGF expression in colon cancer cells. Oncol. Rep., 20, 1321-1327.
37. Rohatgi,N. et al. (2006) Novel molecular targets of smokeless tobacco (khaini) in cell culture from oral hyperplasia. Toxicology., 224, 1-13.
38. Macha,M.A. et al. (2010) Clinical significance of TC21 overexpression in oral cancer. J. Oral. Pathol. Med., 39, 477-485.
39. Deeb,D. et al. (2004) Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. Mol. Cancer Ther., 3, 803-812.
40. Shishodia,S. et al. (2004) Guggulsterone inhibits NF-kappaB and Ikappa-Balpha kinase activation, suppresses expression of anti-apoptotic gene products, and enhances apoptosis. J. Biol. Chem., 279, 47148-47158.
41. Sriuranpong,V. et al. (2003) Epidermal growth factor receptor-independent constitutive activation of STAT3 in head and neck squamous cell carcinoma is mediated by the autocrine/paracrine stimulation of the interleukin 6/gp130 cytokine system. Cancer Res., 63, 2948-2956.
42. Arredondo,J. et al. (2006) Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of alpha7 nicotinic receptor in oral keratinocytes. FASEB J., 20, 2093-2101.
43. Ichikawa,H. et al. (2006) Guggulsterone inhibits osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand and by tumor cells by suppressing nuclear factor-kappaB activation. Clin. Cancer Res., 12, 662-668.
44. Cheon,J.H. et al. (2006) Plant sterol guggulsterone inhibits nuclear factorkappaB signaling in intestinal epithelial cells by blocking IkappaB kinase and ameliorates acute murine colitis. Inflamm. Bowel Dis., 12, 1152-1161.
45. Nagpal,J.K. et al. (2002) Activation of Stat-3 as one of the early events in tobacco chewing-mediated oral carcinogenesis. Cancer, 94, 2393-2400.
46. Macha,M.A. et al. (2010) 14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in Head and Neck cancer cells. BMC Cancer, 10, 655.
47. Sinibaldi,D. et al. (2000) Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene, 19, 5419-5427.
48. Uddin,S. et al. (2010) Cyclooxygenase-2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer. Int. J. Cancer, 126, 382-394.
49. Lei,T. et al. (2007) The potential role of Id1 in COX-2 mediated angiogenesis in gastric cancer. Zhonghua Yi Xue Za Zhi, 87, 1570-1575.
50. Harris,R.E. (2007) Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer. Subcell. Biochem., 42, 93-126.